Julius Njogu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Julius Njogu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Beatrice Wasunna
Malaria Public Health and Epidemiology Group, KEMRI/Wellcome Trust Research Programme, Centre for Geographic Medicine Research-Coast (CGMRC), Nairobi, Kenya Nairobi, Kenya
1 shared publication - Beth B. Kangwana
Malaria Public Health & Epidemiology Group, Kenya Medical Research Institute - Wellcome Trust Research Programme, Kenya
1 shared publication - Catherine Goodman
Health Systems and Social Science Research Group, KEMRI-Wellcome Trust Research Programme, Box 43640-00100, Nairobi, Kenya
1 shared publication - Dejan Zurovac
Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, CCVTM, Oxford, UK
1 shared publication - Dorothy Memusi
Division of Malaria Control, Ministry of Health, Nairobi, Kenya
1 shared publication - Robert William Snow
Population and Health Impact Surveillance Group, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya
1 shared publication
Latest Publications
- Open Access
- 1 May 2009
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 80 (5) , 737-738
Malaria Drug Shortages in Kenya: A Major Failure to Provide Access to Effective Treatment
A key bench mark of successful therapeutic policy implementation, and thus effectiveness, is that the recommended drugs are available at the point of care. Two years after artemether-lumefathrine (AL) was introduced for the management of uncomplicated malaria in Kenya, we carried out a cross-sectional survey to investigate AL availability in government facilities in seven malaria-endemic districts. One of four of the surveyed facilities had none of the four AL weight-specific treatment packs in stock; three of four facilities were out of stock of at least one weight-specific AL pack, leading health workers to prescribe a range of inappropriate alternatives. The shortage was in large part caused by a delayed procurement process. National ministries of health and the international community must address the current shortcomings facing antimalarial drug supply to the public sector.
- 1 May 2009
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 80 (5) , 737-738
Open AccessMalaria Drug Shortages in Kenya: A Major Failure to Provide Access to Effective Treatment
A key bench mark of successful therapeutic policy implementation, and thus effectiveness, is that the recommended drugs are available at the point of care. Two years after artemether-lumefathrine (AL) was introduced for the management of uncomplicated malaria in Kenya, we carried out a cross-sectional survey to investigate AL availability in government facilities in seven malaria-endemic districts. One of four of the surveyed facilities had none of the four AL weight-specific treatment packs in stock; three of four facilities were out of stock of at least one weight-specific AL pack, leading health workers to prescribe a range of inappropriate alternatives. The shortage was in large part caused by a delayed procurement process. National ministries of health and the international community must address the current shortcomings facing antimalarial drug supply to the public sector.